F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Chronic Hepatitis B

Page 1 of 4 ( 191 items )
<<
1
2
3
4
>>

1	Risk factors and predictive model for hepatitis B virus deoxyribonucleic acid elevation in mid-to-late pregnancy with low viremia 10/21/2026 2:09:39 AM \| Browse: 24 \| Download: 49
2	Pegylated interferon α-2b add-on to nucleos(t)ide analogues reduces hepatocellular carcinoma and decompensation in advanced fibrotic chronic hepatitis B 10/15/2026 5:45:55 AM \| Browse: 39 \| Download: 99
3	From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B 9/17/2026 5:48:20 AM \| Browse: 34 \| Download: 72
4	Biological interpretation of baseline hepatitis B surface antigen and cirrhosis in determining interferon treatment duration 9/7/2026 2:26:33 AM \| Browse: 56 \| Download: 99
5	Predictive model to identify patients requiring extended interferon therapy in chronic hepatitis B 9/1/2026 6:22:40 AM \| Browse: 35 \| Download: 83
6	Routine laboratory model for identifying significant fibrosis in chronic hepatitis B 6/26/2026 9:50:21 AM \| Browse: 61 \| Download: 284
7	Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines 6/26/2026 9:50:19 AM \| Browse: 46 \| Download: 219
8	Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B 6/18/2026 7:52:55 AM \| Browse: 62 \| Download: 260
9	Bone and renal safety of initial antiviral therapy using tenofovir alafenamide fumarate or entecavir for chronic hepatitis B 5/29/2026 7:26:46 AM \| Browse: 62 \| Download: 363
10	Beyond fibrosis: The imperative for dual steatosis and fibrosis assessment in chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease co-pathology 5/26/2026 3:52:09 AM \| Browse: 46 \| Download: 212
11	Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study 5/26/2026 3:52:08 AM \| Browse: 69 \| Download: 308
12	Why does hepatitis B remain underprioritized? A view through lived experience 4/23/2026 11:05:50 AM \| Browse: 110 \| Download: 356
13	Baseline hepatitis B surface antigen and cirrhosis predict extended interferon therapy in chronic hepatitis B: A retrospective study 3/19/2026 7:07:29 AM \| Browse: 105 \| Download: 415
14	Predictive tool for evident histological liver injury in chronic hepatitis B patients: Development and validation 2/12/2026 11:20:21 AM \| Browse: 149 \| Download: 618
15	Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B 2/12/2026 11:20:19 AM \| Browse: 150 \| Download: 607
16	Adherence to antiviral treatment among people living with chronic hepatitis B: A global survey 12/25/2025 9:13:55 AM \| Browse: 125 \| Download: 549
17	Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B 11/28/2025 3:10:38 AM \| Browse: 315 \| Download: 643
18	Meta-analysis of factors associated with the incidence of comorbid depression and anxiety in patients with chronic hepatitis B 11/4/2025 2:41:47 AM \| Browse: 330 \| Download: 799
19	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 449 \| Download: 629
20	Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B 10/24/2025 7:36:34 AM \| Browse: 372 \| Download: 579
21	Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B 10/24/2025 7:36:26 AM \| Browse: 224 \| Download: 479
22	Psychological distress and treatment adherence-challenges of patients with chronic hepatitis B: Risk factors and integrated nursing strategies 9/26/2025 8:18:47 AM \| Browse: 582 \| Download: 590
23	Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report 9/25/2025 11:24:05 AM \| Browse: 196 \| Download: 604
24	Anti-hepatitis B virus effects of traditional Chinese medicine: Learning from clinical trials in the past twenty years 9/25/2025 11:24:00 AM \| Browse: 438 \| Download: 562
25	Chronic hepatitis B: Is it time for expanded antiviral treatment? 9/25/2025 9:22:03 AM \| Browse: 291 \| Download: 440
26	Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics 7/25/2025 12:09:41 PM \| Browse: 318 \| Download: 722
27	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 326 \| Download: 1063
28	Rate of abnormal renal function index and related risk factors in patients with chronic hepatitis B 7/4/2025 9:23:52 AM \| Browse: 228 \| Download: 1001
29	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 391 \| Download: 1232
30	Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease 5/27/2025 7:04:47 AM \| Browse: 340 \| Download: 989
31	Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients 3/13/2025 10:11:05 AM \| Browse: 295 \| Download: 982
32	Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment 2/26/2025 4:21:35 AM \| Browse: 296 \| Download: 705
33	CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment 12/20/2024 3:53:46 AM \| Browse: 117 \| Download: 583
34	Current status of drug therapy for chronic hepatitis B 12/18/2024 7:36:02 AM \| Browse: 348 \| Download: 913
35	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 401 \| Download: 1122
36	Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus 11/29/2024 2:50:18 PM \| Browse: 396 \| Download: 1384
37	Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens 11/12/2024 6:08:07 AM \| Browse: 193 \| Download: 1237
38	Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action 11/6/2024 9:50:59 AM \| Browse: 327 \| Download: 1070
39	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 371 \| Download: 966
40	Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return 10/21/2024 7:03:25 AM \| Browse: 377 \| Download: 878
41	Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered 7/26/2024 10:33:30 AM \| Browse: 402 \| Download: 1220
42	Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis 7/26/2024 10:33:30 AM \| Browse: 456 \| Download: 1774
43	Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients 7/9/2024 2:00:35 PM \| Browse: 319 \| Download: 840
44	Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors 6/25/2024 10:41:21 AM \| Browse: 429 \| Download: 842
45	Hepatitis B cure: Current situation and prospects 6/20/2024 3:42:22 AM \| Browse: 382 \| Download: 1071
46	Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase 6/20/2024 3:42:22 AM \| Browse: 250 \| Download: 1423
47	Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy 3/27/2024 1:28:19 PM \| Browse: 416 \| Download: 1538
48	Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study 3/11/2024 2:44:49 PM \| Browse: 535 \| Download: 1557
49	Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis 3/6/2024 6:10:52 AM \| Browse: 509 \| Download: 1401
50	Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study 2/4/2024 10:57:42 AM \| Browse: 574 \| Download: 1848

Page 1 of 4 ( 191 items )
<<
1
2
3
4
>>

1	Risk factors and predictive model for hepatitis B virus deoxyribonucleic acid elevation in mid-to-late pregnancy with low viremia 10/21/2026 2:09:39 AM \| Browse: 24 \| Download: 49
2	Pegylated interferon α-2b add-on to nucleos(t)ide analogues reduces hepatocellular carcinoma and decompensation in advanced fibrotic chronic hepatitis B 10/15/2026 5:45:55 AM \| Browse: 39 \| Download: 99
3	From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B 9/17/2026 5:48:20 AM \| Browse: 34 \| Download: 72
4	Biological interpretation of baseline hepatitis B surface antigen and cirrhosis in determining interferon treatment duration 9/7/2026 2:26:33 AM \| Browse: 56 \| Download: 99
5	Predictive model to identify patients requiring extended interferon therapy in chronic hepatitis B 9/1/2026 6:22:40 AM \| Browse: 35 \| Download: 83
6	Routine laboratory model for identifying significant fibrosis in chronic hepatitis B 6/26/2026 9:50:21 AM \| Browse: 61 \| Download: 284
7	Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines 6/26/2026 9:50:19 AM \| Browse: 46 \| Download: 219
8	Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B 6/18/2026 7:52:55 AM \| Browse: 62 \| Download: 260
9	Bone and renal safety of initial antiviral therapy using tenofovir alafenamide fumarate or entecavir for chronic hepatitis B 5/29/2026 7:26:46 AM \| Browse: 62 \| Download: 363
10	Beyond fibrosis: The imperative for dual steatosis and fibrosis assessment in chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease co-pathology 5/26/2026 3:52:09 AM \| Browse: 46 \| Download: 212
11	Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study 5/26/2026 3:52:08 AM \| Browse: 69 \| Download: 308
12	Why does hepatitis B remain underprioritized? A view through lived experience 4/23/2026 11:05:50 AM \| Browse: 110 \| Download: 356
13	Baseline hepatitis B surface antigen and cirrhosis predict extended interferon therapy in chronic hepatitis B: A retrospective study 3/19/2026 7:07:29 AM \| Browse: 105 \| Download: 415
14	Predictive tool for evident histological liver injury in chronic hepatitis B patients: Development and validation 2/12/2026 11:20:21 AM \| Browse: 149 \| Download: 618
15	Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B 2/12/2026 11:20:19 AM \| Browse: 150 \| Download: 607
16	Adherence to antiviral treatment among people living with chronic hepatitis B: A global survey 12/25/2025 9:13:55 AM \| Browse: 125 \| Download: 549
17	Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B 11/28/2025 3:10:38 AM \| Browse: 315 \| Download: 643
18	Meta-analysis of factors associated with the incidence of comorbid depression and anxiety in patients with chronic hepatitis B 11/4/2025 2:41:47 AM \| Browse: 330 \| Download: 799
19	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 449 \| Download: 629
20	Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B 10/24/2025 7:36:34 AM \| Browse: 372 \| Download: 579
21	Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B 10/24/2025 7:36:26 AM \| Browse: 224 \| Download: 479
22	Psychological distress and treatment adherence-challenges of patients with chronic hepatitis B: Risk factors and integrated nursing strategies 9/26/2025 8:18:47 AM \| Browse: 582 \| Download: 590
23	Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report 9/25/2025 11:24:05 AM \| Browse: 196 \| Download: 604
24	Anti-hepatitis B virus effects of traditional Chinese medicine: Learning from clinical trials in the past twenty years 9/25/2025 11:24:00 AM \| Browse: 438 \| Download: 562
25	Chronic hepatitis B: Is it time for expanded antiviral treatment? 9/25/2025 9:22:03 AM \| Browse: 291 \| Download: 440
26	Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics 7/25/2025 12:09:41 PM \| Browse: 318 \| Download: 722
27	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 326 \| Download: 1063
28	Rate of abnormal renal function index and related risk factors in patients with chronic hepatitis B 7/4/2025 9:23:52 AM \| Browse: 228 \| Download: 1001
29	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 391 \| Download: 1232
30	Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease 5/27/2025 7:04:47 AM \| Browse: 340 \| Download: 989
31	Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients 3/13/2025 10:11:05 AM \| Browse: 295 \| Download: 982
32	Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment 2/26/2025 4:21:35 AM \| Browse: 296 \| Download: 705
33	CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment 12/20/2024 3:53:46 AM \| Browse: 117 \| Download: 583
34	Current status of drug therapy for chronic hepatitis B 12/18/2024 7:36:02 AM \| Browse: 348 \| Download: 913
35	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 401 \| Download: 1122
36	Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus 11/29/2024 2:50:18 PM \| Browse: 396 \| Download: 1384
37	Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens 11/12/2024 6:08:07 AM \| Browse: 193 \| Download: 1237
38	Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action 11/6/2024 9:50:59 AM \| Browse: 327 \| Download: 1070
39	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 371 \| Download: 966
40	Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return 10/21/2024 7:03:25 AM \| Browse: 377 \| Download: 878
41	Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered 7/26/2024 10:33:30 AM \| Browse: 402 \| Download: 1220
42	Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis 7/26/2024 10:33:30 AM \| Browse: 456 \| Download: 1774
43	Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients 7/9/2024 2:00:35 PM \| Browse: 319 \| Download: 840
44	Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors 6/25/2024 10:41:21 AM \| Browse: 429 \| Download: 842
45	Hepatitis B cure: Current situation and prospects 6/20/2024 3:42:22 AM \| Browse: 382 \| Download: 1071
46	Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase 6/20/2024 3:42:22 AM \| Browse: 250 \| Download: 1423
47	Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy 3/27/2024 1:28:19 PM \| Browse: 416 \| Download: 1538
48	Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study 3/11/2024 2:44:49 PM \| Browse: 535 \| Download: 1557
49	Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis 3/6/2024 6:10:52 AM \| Browse: 509 \| Download: 1401
50	Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study 2/4/2024 10:57:42 AM \| Browse: 574 \| Download: 1848